Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse potential of gabapentin enacarbil immediate release in recreational drug users
NCT06097676Phase 4Completed
- Start
- Sep 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gabapentin enacarbil in restless legs syndrome (RLS), postherpetic neuralgia (PHN). Started Sep 2021; status: completed.
02
Drugs
gabapentin enacarbil
03
Conditions
restless legs syndrome (RLS)postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT06097676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06097676.